MERCK & CO. Inc., is a leading international research-driven pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products and services. MERCK's commitment to research is unsurpassed in the pharmaceutical industry; it has been estimated that MERCK now conducts approximately 5% of the world's total pharmaceutical research. MERCK plans to spend more than $1.7 billion USD on research in 1997. Since 1992, we have donated over $1.5 million USD of our products, including antibiotics and vaccines, to various hospitals, to the Ministry of Health, and to the Ministry of Defense, in Ukraine. One of our main objectives is to share the most up-to-date scientific information with physicians throughout Ukraine. To date, MSD has registered 23 products in Ukraine, including products to treat serious infections, high blood pressure, congestive heart failure, high cholesterol levels, arthritis, Parkinson's disease, glaucoma, osteoporosis, a vaccine against hepatitis B, and others.